Yale Receives $27.7M Grant to Advance Individualized Autism Therapies
In a groundbreaking new initiative, the Yale School of Medicine has received a $27.7 million grant from the Aligning Research to Impact Autism (ARIA) program to advance autism research. This project aims to develop non-invasive, personalized therapies by using cutting-edge brain imaging, artificial intelligence, and “digital twin” technology to better understand communication and developmental differences in children with autism.
“For families navigating autism, this research offers hope for more targeted care, earlier interventions, and better long-term outcomes,” said Dr. Nancy J. Brown, Dean of Yale School of Medicine. “It has the potential to change fundamentally how we treat children with severe neurodevelopmental disorders.”
By combining data from individuals with autism, drug-resistant epilepsy, and Angelman syndrome, researchers aim to uncover shared neurological patterns that impact communication, anxiety, and sleep. More than 30 experts across fields like neurology, psychiatry, engineering, and data science are collaborating on this effort to create personalized treatment strategies that could transform autism care for families worldwide.
